Melalite Cream | Generic Aclaro | Dosage | Uses | Side effects

Melalite Cream (Generic Aclaro) - Active Ingredient And Chemical structure

The active ingredient contained in Melalite Cream is Hydroquinone USP 4% . Hydroquinone occurs as fine white needles. This medication is freely soluble in water and alcohol. The structure is shown below

Generic Forms and Brand names of Aclaro

Melalite Cream manufactured by Abbott India Ltd., is an effective treatment to lighten areas of darkened skin such as freckles, age spots, chloasma, and melasma (dark skin discoloration).
Aclaro which has the active ingredient Hydroquinone is also sold as Hydroquinone Topical Cream, Alera, Alphaquin HP, Alustra, Claripel, Eldopaque, Eldoquin, Eldoquin Forte, EpiQuin Micro, Esoterica, Glyquin, Glyquin-XM, Hydroquinone cream, Lustra, Melpaque HP, Melquin HP, Melquin-3, Nuquin HP, Solaquin, Melanex, Melanol, Viquin Forte, Esoterica Sensitive Skin, Nava-SC, Remergent HQ, EpiQuin Micro Pump and under various other brand names.

Melalite Cream (Generic Aclaro) - Uses

Melalite Cream (Hydroquinone Topical Cream) in the form of Melalite Cream is used for the gradual treatment of ultraviolet induced dyschromia and discolation resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy or skin trauma.

Melalite Cream - Preparations

Melalite Cream is available as tubes of 30 grams of cream. The strength is 4 %w/w.

Melalite Cream - Contraindications

Melalite Cream is contraindicated in persons that have a hypersensitivity or allergic reaction to Hydroquinone or any inactive ingredient present in the medication.

Melalite Cream - Warnings

The active ingredient present in Melalite Cream is a depigmenting agent which may produce unwanted cosmetic effects if not used as directed. Skin sensitivity has to be tested before using Melalite Cream by appling a small amount to an unbroken patch of skin and checking it within 24 hours. In case there is itching, vescile formation, or exessive inflammatory response further treatment is not advised. Contact with eyes should be avoided. If no lightening effect is observed after two months of treatment use of Melalite cream should be avoided.

Melalite Cream (Generic Aclaro) - Storage Requirements

Melalite Cream (Generic Aclaro) are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light. Keep away from children.

Melalite Cream (Generic Aclaro) - Dosage

Melalite Cream should be applied to the affected areas twice daily or as directed by your doctor.

Side Effects Of Melalite Cream (Generic Aclaro)

The most common side effects of Melalite Cream (Generic Aclaro) are cutaneous hypersensitivity (localised contact dermatitis) in which case treatment should be stopped and the doctor should be notified immediately. No systemic reactions have been reported.

Further Information

Prescribing Information

Flutivate Cream | Generic Cutivate | Dosage | Uses | Side effects

Flutivate Cream (Generic Cutivate) - Active Ingredient And Chemical structure

The active ingredient contained in Flutivate Cream is Fluticasone Propionate. Fluticasone propionate is a white powder with a molecular weight of 500.6, It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol.The structure is shown below

Flutivate Cream (Generic Cutivate) - Uses

Generic Cutivate in the form of Flutivate Cream is used to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Generic Forms and Brand names of Cutivate

Flutivate Cream manufactured by GlaxoSmithKline, India is an effective treatment for eczema, psoriasis, allergies and rash. Cutivate which has the active ingredient Fluticasone Propionate is also sold under various other brand names.

Flutivate Cream (Generic Cutivate) - Preparations

Flutivate Cream is available as tubes of 20 g tubes containing Fluticasone Propionate IP 0.005% w/w.

Flutivate Cream (Generic Cutivate) - Contraindications

Flutivate Cream (Fluticasone propionate cream, 0.05%) is contraindicated in patients with a hypersensitivity to Fluticasone propionate or any of the inactive ingredients present in Flutivate cream. The preparation also contraindicated in the treatment of rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (i.e., herpes simplex, chickenpox), perianal and genital pruritus, primarily infected skin lesions caused by infection with fungi or bacteria and dermatoses in children, including dermatitis and diaper rash.

Flutivate Cream (Generic Cutivate) - Storage Requirements

Flutivate Cream is to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Flutivate Cream (Generic Cutivate) - Overdose

In case of Overdosage , treatment should be discontinued if the symptoms of hypercorticism appear. Topically applied fluticasone propionate cream, 0.05% can be absorbed in sufficient amounts to produce systemic effects.

Flutivate Cream (Generic Cutivate) - Dosage

The dosage of Flutivate cream to treat various indications is given below.
Eczema: Apply a thin film of Flutivate Cream (fluticasone propionate) Cream to the affected skin areas once or twice daily. Rub in gently.
Other Corticosteroid Responsive Dermatoses: Apply a thin film of Flutivate Cream 0.05% to the affected skin areas twice daily . Rub in gently.

Side Effects Of Flutivate Cream (Generic Cutivate)

The total occurence of side effects associated with the use of Flutivate Cream (fluticasone propionate cream, 0.05% ) was approximately 4%. These adverse reactions were mild and self-limiting. For fluticasone propionate cream 0.05%, these reactions consisted primarily of pruritus, dryness, numbness of fingers, and burning.

T-Bact Ointment | Generic Bactroban Cream | Dosage | Uses | Side effects

T-Bact Ointment (Generic Bactroban Cream) - Active Ingredient And Chemical structure

The active ingredient contained in T-Bact Ointment is Mupirocin. Mupirocin is a naturally occurring antibiotic. The structure is shown below

T-Bact Ointment (Generic Bactroban Cream) - Uses

Generic Bactroban Cream in the form of T-Bact Ointment is used for the topical treatment of impetigo due to S. aureus and S. pyogenes.

Generic Forms and Brand names of Bactroban Cream

T-Bact Ointment manufactured by GlaxoSmithKline, India is an effective treatment for impetigo and small wounds which have become infected. These wounds may include small cuts and abrasions or stitches. Bactroban Cream which has the active ingredient Mupirocin is also sold as Centany and under various other brand names.

T-Bact Ointment - Preparations

T-Bact Ointment is available as 5 g tubes containing Mupirocin USP 2.0% w/w. Each gram of T-Bact Ointment (mupirocin ointment, 2%) contains 20 mg mupirocin in a bland water miscible ointment base.

T-Bact Ointment (Generic Bactroban Cream) - Contraindications

T-Bact Ointment is contraindicated in individuals with a history of sensitivity reactions to Mupirocin or any of its inactive ingredients.

T-Bact Ointment (Generic Bactroban Cream) - Storage Requirements

T-Bact Ointment is to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

T-Bact Ointment - Dosage

A small amount of T-Bact Ointment should be applied to the affected area three times daily. The area under treatment can be covered with a gauze dressing if desired.

T-Bact Ointment - Pediatric Use

The safety and effectiveness of T-Bact Ointment (mupirocin ointment, 2%) have been established in the age range of 2 months to 16 years. The use of Mupirocin ointment in these age groups is supported by evidence from adequate and well-controlled studies of Bactroban ointment in impetigo in pediatric patients.

T-Bact Ointment - Precautions

If a reaction takes place that suggests sensitivity or chemical irritation occurs with the use of T-Bact Ointment treatment should be discontinued and appropriate alternative therapy for the infection should be instituted. As with other antibacterial products, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi.

Side Effects Of T-Bact Ointment (Generic Bactroban Cream)

The most common side effects of T-Bact Ointment are Burning, stinging, or pain in 1.5% of patients; itching in 1% of patients; rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis, and increased exudate in less than 1% of patients. Systemic reactions to T-Bact Ointment have rarely occurred.

Further Information

Prescribing Information

Acetec Capsules | Generic Soriatane | Dosage | Uses | Side effects

Acetec Capsules (Generic Soriatane) - Active Ingredient And Chemical structure

The active ingredient contained in Acetec Capsules (Generic Soriatane) is Acitretin, a retinoid. Acitretin is a yellow to greenish-yellow powder with a molecular weight of 326.44. The structure is shown below

Acetec Capsules (Generic Soriatane) - Uses

Generic Soriatane in the form of Acetec Capsules is used to treat severe psoriasis in adults. As there exists significant adverse effects associated with its use, Soriatane should be prescribed only by those knowledgeable in the systemic use of retinoids. In the case of females of reproductive potential,
Soriatane should be administered only to non-pregnant patients who are not responsive to other medications or whose clinical condition contraindicates the use of other treatments.

Generic Forms and Brand names of Soriatane

Acetec Capsules manufactured by Dr Reddy's Laboratories Ltd., India is an effective treatment for severe resistant psoriasis in adults. Soriatane which has the active ingredient Acitretin is also sold as Generic Acitretin, Soriatane, Aceret or Acitrin and under various other brand names.

Acetec Capsules - Preparations

Acetec is available as Capsules of 10 mg and 25 mg for oral administration.

Acetec Capsules (Generic Soriatane) - Storage Requirements

Acetec Capsules (Generic Soriatane) are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Acetec Capsules (Generic Soriatane) - Contraindications

Generic Soriatane must not be used by females who are pregnant, or who intend to become pregnant during therapy or at any time for at least 3 years following discontinuation of therapy.
Acetec Capsules (Generic Soriatane) is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values. An increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate. Consequently, the combination of methotrexate with Generic Soriatane is also contraindicated.
Similarly both Soriatane and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated. Acetec Capsules (Generic Soriatane) is contraindicated in cases of hypersensitivity to acitretin or any inactive ingredient present in the medication or to other retinoids.

Acetec Capsules (Generic Soriatane) - Dosage

Acetec Capsules therapy should be initiated for adults at 25 to 50 mg per day, given as a single dose with the main meal. Maintenance doses of 25 to 50 mg per day may be given dependent upon an individual patient’s response to initial treatment. Relapses may be treated as outlined for initial therapy.

Side Effects Of Acetec Capsules (Generic Soriatane)

Hypervitaminosis A produces a wide spectrum of signs and symptoms primarily of the mucocutaneous, musculoskeletal, hepatic, neuropsychiatric, and central nervous systems. Many of the clinical adverse reactions reported to date with Generic Soriatane administration resemble those of the hypervitaminosis A syndrome. The side effects of Acetec Capsules (Generic Soriatane) are listed below:
Cardiovascular: Acute myocardial infarction, thromboembolism, stroke
Nervous System: Myopathy with peripheral neuropathy has been reported during Soriatane therapy. Both conditions improved with discontinuation of the drug.
Psychiatric: Aggressive feelings and/or suicidal thoughts have been reported. These events, including self-injurious behavior, have been reported in patients taking other systemically administered retinoids, as well as in patients taking Soriatane.
Reproductive: Vulvo-vaginitis due to Candida albicans
Skin and Appendages: Thinning of the skin, skin fragility and scaling may occur all over the body, particularly on the palms and soles; nail fragility is frequently observed.
The other reported side effects include:
Central Nervous System
Rigors
Eye Disorders
Xerophthalmia
Mucous Membranes
Cheilitis, Rhinitis, Dry mouth, Epistaxis
Musculoskeletal
Arthralgia
Spinal hyperostosis(progression of existing lesions)
Skin and Appendages
Alopecia, Dry skin, Erythematous rash, Skin peeling, Nail disorder, Hyperesthesia, Pruritus, Paresthesia, Paronychia,Skin atrophy, Sticky skin

Further Information

Prescribing Information

E2 Vaginal Tablets | Generic Vagifem Pessaries | Dosage | Uses | Side effects

E2 Vaginal Tablets (Generic Vagifem Pessaries) - Active Ingredient And Chemical structure

The active ingredient contained in Generic Vagifem Pessaries is Estradiol ( also referred to as oestradiol). Oestradiol which is in Vagifem is a natural type of oestrogen. Estradiol hemihydrate is a white, almost white or colorless crystalline solid. The structure is shown below

E2 Vaginal Tablets (Generic Vagifem) - Uses

Generic Vagifem in the form of E2 Vaginal Tablets is used for the treatment of certain vaginal symptoms which occur after menopause, such as dryness, itchiness and pain during sexual intercourse. This is caused by a drop in the level of a hormone called oestrogen. However, your doctor may prescribe this medicine for another use.

Generic Forms and Brand names of Vagifem Pessaries

E2 Vaginal Tablets manufactured by Sun Pharmaceuticals Ltd., India is an effective treatment for vaginal conditions caused by menopause or a deficiency of estrogen hormone. Vagifem which has the active ingredient Estradiol is also sold as Vagifem Suppository, Estradiol, Estrace, Estring, Femring, Estring Ring and under various other brand names.

E2 Vaginal Tablets - Preparations

E2 Vaginal Tablets are available as tablets of 2 mg.

E2 Vaginal Tablets (Generic Vagifem) - Contraindications

E2 Vaginal Tablets (Generic Vagifem) should not be used in women with any of the following conditions:
(1)Known allergy to oestradiol or any inactive ingredient present in Generic Vagifem
(2)Undiagnosed abnormal genital bleeding
(3)Known, suspected, or history of breast cancer
(4)Known or suspected estrogen-dependent neoplasia
(5)Active deep vein thrombosis, pulmonary embolism or history of these conditions
(6)Active arterial thromboembolic disease (for example, stroke, and myocardial infarction), or a history of these conditions
(7)Known liver dysfunction or disease
(8) Known or suspected pregnancy

E2 Vaginal Tablets (Generic Vagifem) - Storage Requirements

E2 Vaginal Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

E2 Vaginal Tablets (Generic Vagifem) - Warnings and Precautions

The warnings and precautions to be taken when using E2 Vaginal Tablets (Generic Vagifem) are given below:
Estrogens increase the risk of gallbladder disease
Discontinue estrogen if severe hypercalcemia, loss of vision, severe hypertriglyceridemia or cholestatic jaundice occurs
The Vagifem applicator may cause vaginal abrasion
Monitor thyroid function in women on thyroid replacement therapy

E2 Vaginal Tablets (Generic Vagifem) - Dosage

E2 Vaginal Tablets (Generic Vagifem) should be administered intravaginally. The recommended dose is 1 tablet daily for 2 weeks, followed by 1 tablet twice weekly.

Side Effects Of E2 Vaginal Tablets (Generic Vagifem)

The most common side effects of E2 Vaginal Tablets (Generic Vagifem) with an incidence rate of 5% or greater are upper respiratory tract infection, headache, abdominal pain, back pain, genital pruritis, moniliasis, vulvovaginal mycotic infection and diarrhea.

Further Information

Prescribing Information

Isotroin Capsules | Generic Accutane | Dosage | Uses | Side effects

Isotroin Capsules (Generic Accutane) - Active Ingredient And Chemical structure

The active ingredient contained in Isotroin Capsules is Isotretinoin. Isotretinoin, a retinoid, is a yellow to orange crystalline powder with a molecular weight of 300.44. It is available as Isotroin Capsules (Generic Accutane) in 10 mg and 20 mg capsules for oral administration.The structure is shown below

Isotroin Capsules - Uses

Accutane in the form of Isotroin Capsules is used for the treatment of severe recalcitrant nodular acne. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic.

Generic Forms and Brand names of Accutane

Isotroin Capsules manufactured by Cipla Ltd., India is an effective treatment for moderate to severe acne that has failed other therapies. Accutane which has the active ingredient Isotretinoin is also sold as Sotret, Claravis, Amnesteem, Roaccutane, Clarus, Decutan, Isotane, Izotek, Oratane, Isotret and under various other brand names.

Isotroin Capsules - Preparations

Isotroin Capsules (Generic Accutane) is available as tablets of 10 mg and 20 mg.

Isotroin Capsules - Storage Requirements

Isotroin Capsules are to be stored at controlled room temperature (15°C to 30°C). Protect from light. Store away from heat and moisture.

Isotroin Capsules (Generic Accutane) - Contraindications

Isotroin Capsules (Generic Accutane) is contraindicated in patients who are hypersensitive to Isotretinoin or any inactive ingredient present in this medication. Generic Accutane should not be given to patients who are sensitive to parabens, which are used as preservatives in the gelatin capsule.

Isotroin Capsules (Generic Accutane) - Warnings

Isotroin Capsules (Generic Accutane) must not be used by female patients who are or may become pregnant. There is an extremely high risk that severe birth defects will result if pregnancy occurs while taking Accutane in any amount, even for short periods of time. Potentially any fetus exposed during pregnancy can be affected. There are no accurate means of determining whether an exposed fetus has been affected.
As there are significant adverse effects associated with its use, Isotroin Capsules should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.

Isotroin Capsules (Generic Accutane) - Dosage

Generic Accutane should always be administered with a meal. The recommended dosage range for Isotroin Capsules is 0.5 to 1.0 mg/kg/day given in two divided doses with food for 15 to 20 weeks.
In studies which compared 0.1, 0.5, and 1.0 mg/kg/day, it was found that all dosages provided initial clearing of the disease, but there was a greater need for retreatment with the lower dosages. During treatment, the Generic Accutane dose may be adjusted according to response of the disease and/or the appearance of clinical side effects — some of which may be dose related.

Side Effects Of Isotroin Capsules (Generic Accutane)

The most common side effects of Isotroin Capsules are listed below:
Body as a Whole
allergic reactions, including vasculitis, systemic hypersensitivity, edema, fatigue, lymphadenopathy, weight loss
Cardiovascular
palpitation, tachycardia, vascular thrombotic disease, stroke
Endocrine/Metabolic
hypertriglyceridemia, alterations in blood sugar levels
Gastrointestinal
inflammatory bowel disease, hepatitis, pancreatitis, bleeding and inflammation of the gums, colitis, esophagitis/esophageal ulceration, ileitis, nausea, other nonspecific gastrointestinal symptoms
Hematologic
allergic reactions, anemia, thrombocytopenia, neutropenia, rare reports of agranulocytosis.
Musculoskeletal
skeletal hyperostosis, calcification of tendons and ligaments, premature epiphyseal closure, decreases in bone mineral density, musculoskeletal symptoms including back pain, myalgia, and arthralgia, transient pain in the chest, arthritis, tendonitis, other types of bone abnormalities, elevations of CPK/rare reports of rhabdomyolysis.
Neurological
pseudotumor cerebri, dizziness, drowsiness, headache, insomnia, lethargy, malaise, nervousness, paresthesias, seizures, stroke, syncope, weakness
Psychiatric
suicidal ideation, suicide attempts, suicide, depression, psychosis, aggression, violent behaviors, emotional instability
Reproductive System
abnormal menses
Respiratory
bronchospasms (with or without a history of asthma), respiratory infection, voice alteration
Skin and Appendages
acne fulminans, alopecia (which in some cases persists), bruising, cheilitis (dry lips), dry mouth, dry nose, dry skin, epistaxis, eruptive xanthomas, erythema multiforme, flushing, fragility of skin, hair abnormalities, hirsutism, hyperpigmentation and hypopigmentation, infections (including disseminated herpes simplex), nail dystrophy, paronychia, peeling of palms and soles, photoallergic/photosensitizing reactions, pruritus, pyogenic granuloma, rash (including facial erythema, seborrhea, and eczema), Stevens-Johnson syndrome, sunburn susceptibility increased, sweating, toxic epidermal necrolysis, urticaria, vasculitis (including Wegener’s granulomatosis), abnormal wound healing
Hearing
hearing impairment, tinnitus.
Vision
corneal opacities, decreased night vision which may persist, cataracts, color vision disorder, conjunctivitis, dry eyes, eyelid inflammation, keratitis, optic neuritis, photophobia, visual disturbances
Urinary System
glomerulonephritis, nonspecific urogenital findings

Further Information

Prescribing Information

Montair Tablets | Generic Singulair | Dosage | Uses | Side effects

Montair Tablets (Generic Singulair)- Active Ingredient And Chemical structure

The active ingredient contained in Montair Tablets is Montelukast Sodium . Montelukast sodium is a hygroscopic, optically active, white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water. The structure is shown below

Montair Tablets (Generic Singulair) - Uses

Generic Singulair in the form of Montair Tablets is used to treat the following indications:
(1) Treatment of asthma in adults and pediatric patients 12 months of age and older.
(2)Prevention of exercise-induced bronchoconstriction in patients 15 years of age and older.
(3)Relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older).

Generic Forms and Brand names of Singulair

Montair manufactured by Cipla Ltd., India is an effective treatment for asthma, exercise induced bronchospasm, allergic rhinitis, and urticaria. Singulair which has the active ingredient Montelukast Sodium is also sold under various other brand names.

Montair Tablets - Preparations

Montair is available as tablets of 5 mg and 10 mg . Each film coated tablet contains 5 mg or 10 mg Montelukast Sodium respectively.

Montair Tablets (Generic Singulair) - Storage Requirements

Montair Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Montair Tablets (Generic Singulair) - Contraindications

Montair Tablets (Generic Singulair) are contraindicated in patients that have hypersensitivity to Montelukast sodium or any inactive ingredient of this product.

Montair Tablets (Generic Singulair) - Dosage

The dosage of Montair tablets for various indications is given below
Asthma: Once daily in the evening for patients 12 months and older.
Acute prevention of EIB : 10 mg tablet at least 2 hours before exercise for patients 15 years of age and older.
Seasonal allergic rhinitis : Once daily for patients 2 years and older.
Perennial allergic rhinitis: Once daily for patients 6 months and older.

Side Effects Of Montair Tablets (Generic Singulair)

The most common side effects of are Most common adverse reactions (incidence equal to and greater than 5% are upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, otitis.

Further Information

Prescribing Information

Emeset Tablets | Generic Zofran | Dosage | Uses | Side effects

Emeset Tablets (Generic Zofran) - Active Ingredient And Chemical structure

The active ingredient contained in Emeset Tablets is Ondansetron HCl. Ondansetron HCl dihydrate is a white to off-white powder that is soluble in water and normal saline. The structure is shown below

Generic Zofran (Emeset Tablets) - Uses

Generic Zofran in the form of Emeset Tablets is used for the following Indications:
1.Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin = 50 mg/m2.
2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
3. Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.
4. Prevention of postoperative nausea and/or vomiting. As with other medications used to prevent vomiting and nausea, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron tablets and syrup is recommended even when the incidence of postoperative nausea and/or vomiting is low.

Generic Forms and Brand names of Zofran

Emeset Tablets manufactured by Cipla Ltd., India is an effective treatment for the prevention of nausea and vomiting that may be caused by surgery or by medicine to treat cancer (chemotherapy or radiation). Zofran which has the active ingredient Ondansetron HCl is also sold as Zuplenz, Emetron, Emodan, Ondemet, Setronax, Ondavell and under various other brand names.

Emeset Tablets Preparations

Emeset is available as tablets of 4 mg and 8 mg . Each film coated tablet contains Ondansetron hydrochloride dihydrate Equivalent to Ondansetron 4 mg and 8 mg respectively.

Emeset Tablets - Storage Requirements

Emeset Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Emeset Tablets - Dosage

Prevention of Nausea and Vomiting Associated With Highly Emetogenic Cancer Chemotherapy: The recommended adult oral dosage of Emeset Tablets is 24 mg given as three 8-mg tablets administered 30 minutes before the start of single-day highly emetogenic chemotherapy, including cisplatin = 50 mg/m2.
Prevention of Nausea and Vomiting Associated With Moderately Emetogenic Cancer Chemotherapy: The recommended adult oral dosage is one 8 mg Emeset Tablet given twice a day. The first dose should be administered 30 minutes before the start of emetogenic chemotherapy, with a subsequent dose 8 hours after the first dose. One 8 mg Emeset Tablet should be administered twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy. For pediatric patients 12 years of age and older, the dosage is the same as for adults. For pediatric patients 4 through 11 years of age, the dosage is one 4-mg Emeset Tablet given 3 times a day. The first dose should be administered 30 minutes before the start of emetogenic chemotherapy, with subsequent doses 4 and 8 hours after the first dose. One 4 mg Emeset Tablet should be administered 3 times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
Prevention of Nausea and Vomiting Associated With Radiotherapy, Either Total Body Irradiation, or Single High-Dose Fraction or Daily Fractions to the Abdomen: The recommended oral dosage for adults is one 8 mg Emeset Tablet given 3 times a day.
For total body irradiation, one 8-mg Emeset Tablet should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
For single high-dose fraction radiotherapy to the abdomen, one 8-mg Emeset Tablet should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
For daily fractionated radiotherapy to the abdomen, one 8-mg Emeset Tablet should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting: The recommended dosage is 16 mg given as two 8 mg Emeset Tablets 1 hour before induction of anesthesia.

Emeset Tablets - Contraindications

The concomitant use of apomorphine with ondansetron is contraindicated based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron. Emeset Tablets are contraindicated for patients known to have hypersensitivity to Ondansetron HCl or any inactive ingredient present in the medication.

Emeset Tablets - Overdosage

There is no specific antidote for ondansetron overdose. Patients should be managed with appropriate supportive therapy. Individual intravenous doses as large as 150 mg and total daily intravenous doses as large as 252 mg have been inadvertently administered without significant adverse events. These doses are more than 10 times the recommended daily dose.

Side Effects Of Emeset Tablets (Generic Zofran)

The most common side effects of are Headache, Diarrhea, Malaise/fatigue,
Constipation and Dizziness.

Further Information

Prescribing Information

Risofos Tablets | Generic Actonel | Dosage | Uses | Side effects

Risofos Tablets (Generic Actonel) - Active Ingredient And Chemical structure

The active ingredient contained in Risofos Tablets is Risedronate Sodium. Risedronate sodium is a fine, white to off-white, odorless, crystalline powder. It is soluble in water and in aqueous solutions. The structure is shown below

Generic Actonel (Risofos Tablets) - Uses

Generic Actonel in the form of Risofos Tablets 35 mg is used for Treatment and prevention of postmenopausal osteoporosis, Treatment to increase bone mass in men with osteoporosis, Treatment and prevention of glucocorticoid-induced osteoporosis and Treatment of Paget's disease.
Postmenopausal Osteoporosis
Risofos is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Treatment of Osteoporosis
In postmenopausal women with osteoporosis, risedronate increases Bone Mass Density and reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures.
Prevention of Osteoporosis
Risofos may be considered in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.
Osteoporosis in Men
Risofos is indicated for treatment to increase bone mass in men with osteoporosis.
Glucocorticoid-Induced Osteoporosis
Risofos is indicated for the prevention and treatment of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage equivalent to 7.5 mg or greater of prednisone) for chronic diseases. Patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin D.
Paget`s Disease
Risofos is indicated for treatment of Paget`s disease of bone in men and women. Treatment is indicated in patients with Paget`s disease of bone
(1) who have a level of serum alkaline phosphatase at least 2 times the upper limit of normal, or
(2) who are symptomatic, or
(3) who are at risk for future complications from their disease, to induce remission (normalization of serum alkaline phosphatase).

Generic Forms and Brand names of Actonel

Risofos Tablets manufactured by Cipla Ltd., India is an effective treatment for treating and preventing osteoporosis in certain patients. Actonel which has the active ingredient Risedronate sodium is also sold as Atelvia, Benet and under various other brand names.

Risofos Tablets Preparations

Risofos is available as tablets of 35 mg. Each Risofos Tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate.

Risofos Tablets - Storage Requirements

Risofos Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Risofos Tablets (Generic Actonel) - Dosage

Risofos Tablets should be taken at least 30 minutes before the first food or drink of the day other than water. To facilitate delivery to the stomach, Risofos Tablets (Generic Actonel) should be swallowed while the patient is in an upright position and with a full glass of plain water (6 to 8 oz).
Patients should not lie down for 30 minutes after taking the medication. Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate. Calcium supplements and calcium-, aluminum-, and magnesium-containing medications may interfere with the absorption of Generic Actonel 35 mg and should be taken at a different time of the day.
Risofos is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 mL/min). No dosage adjustment is necessary in patients with a creatinine clearance greter than or equal to 30 mL/min or in the elderly.

Treatment and Prevention of Postmenopausal Osteoporosis
The recommended dosage is one 35 mg tablet orally, taken once a week.
Treatment to Increase Bone Mass in Men with Osteoporosis
The recommended dosage is One 35 mg tablet orally, taken once a week
Treatment and Prevention of Glucocorticoid -Induced Osteoporosis
The recommended dosage is One 35 mg tablet orally, taken once a week.
Paget`s Disease
The recommended dosage for treatment is 30 mg orally once daily for 2 months. Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase. For retreatment, the dose and duration of therapy are the same as for initial treatment.

Risofos Tablets (Generic Actonel) - Contraindications

Risofos Tablets is contraindicated in the following cases:
Hypocalcemia, Known hypersensitivity to Risedronate Sodium or any inactive component of this medication and Inability to stand or sit upright for at least 30 minutes.

Side Effects Of Risofos Tablets (Generic Actonel)

The most common side effects of Generic Actonel are back pain, arthralgia, myalgia, abdominal pain, nausea, and dyspepsia. Rare side effects that may occur are Hypersensitivity reactions (angioedema, generalized rash, bullous skin reactions), and eye inflammation (iritis, uveitis).

Further Information

Additional Info: Prescribing Information

Osteofos Tablets | Generic Fosamax | Dosage | Uses | Side effects

Osteofos Tablets (Generic Fosamax) - Active Ingredient And Chemical structure

The active ingredient contained in Osteofos Tablets is Alendronate Sodium. Alendronate sodium is a white, crystalline, nonhygroscopic powder. It is soluble in water, very slightly soluble in alcohol, and practically insoluble in chloroform. The structure is shown below

Generic Forms and Brand names of Fosamax

Osteofos Tablets manufactured by Cipla Ltd., India is used for treatment and prevention of osteoporosis in postmenopausal women. Fosamax which has the active ingredient Alendronate Sodium is also sold under various other brand names.

Osteofos Tablets Preparations

Osteofos is available as tablets of 10 mg, 35 mg and 70 mg . Each uncoated tablet of Osteofos for oral administration contains Sodium Alendronate BP equivalent to Alendronic acid 10 mg, 35 mg and 70 mg respectively as well as inactive ingredients.

Osteofos Tablets - Storage Requirements

Osteofos Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Generic Fosamax (Osteofos Tablets) - Uses

Generic Fosamax in the form of Osteofos Tablets is used for:
Treatment and prevention of osteoporosis in postmenopausal women
For the treatment of osteoporosis, Generic Fosamax increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures).
Osteoporosis may be confirmed by the finding of low bone mass or by the presence or history of osteoporotic fracture.
For the prevention of osteoporosis , Osteofos Tablets may be considered in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of future fracture.
Treatment to increase bone mass in men with osteoporosis
Treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density. Patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin D.
Treatment of Paget’s disease of bone in men and women
Treatment is indicated in patients with Paget's disease of bone having alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.

Osteofos Tablets - Contraindications

Osteofos Tablets (Generic Fosamax) is contraindicated in the following cases:

• Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia


• Inability to stand or sit upright for at least 30 minutes


• Hypersensitivity to Alendronate Sodium or any inactive ingredient of this medication.


• Hypocalcemia

Osteofos Tablets - Dosage

Osteofos Tablets must be taken at least half an hour before the first food, beverage, or medication of the day with plain water only. Other beverages (including mineral water), food, and some medications are likely to reduce the absorption of Osteofos. Waiting less than 30 minutes, or taking Osteofos with food, beverages (other than plain water) or other medications will lessen the effect of Osteofos by decreasing its absorption into the body.
Generic Fosamax should only be taken upon arising for the day. To facilitate delivery to the stomach and thus reduce the potential for esophageal irritation, an Osteofos tablet should be swallowed with a full glass of water (6-8 oz). Patients should not lie down for at least 30 minutes and until after their first food of the day. Osteofos should not be taken at bedtime or before arising for the day.
Failure to follow these instructions may increase the risk of esophageal adverse experiences Patients should receive supplemental calcium and vitamin D, if dietary intake is inadequate No dosage adjustment is necessary for the elderly or for patients with mild-to-moderate renal insufficiency (creatinine clearance 35 to 60 mL/min). Osteofos is not recommended for patients with more severe renal insufficiency (creatinine clearance less than 35 mL/min) due to lack of experience.
The recommended dosage of Osteofos for the treatment of various indications is given below:
Treatment of osteoporosis in postmenopausal women
The recommended dosage is:
• one 70 mg tablet once weekly
or
• one 10 mg tablet once daily
Treatment to increase bone mass in men with osteoporosis
The recommended dosage is:
• one 70 mg tablet once weekly
or
• one 10 mg tablet once daily
Prevention of osteoporosis in postmenopausal women
The recommended dosage is:
• one 35 mg tablet once weekly
or
one 5 mg tablet once daily
The safety of treatment and prevention of osteoporosis with Osteofos has been studied for up to 7 years.
Treatment of glucocorticoid-induced osteoporosis in men and women
The recommended dosage is one 5 mg tablet once daily, except for postmenopausal women not receiving estrogen, for whom the recommended dosage is one 10 mg tablet once daily.
Paget’s disease of bone in men and women
The recommended treatment regimen is 40 mg once a day for six months.
Retreatment of Paget’s disease
In clinical studies in which patients were followed every six months, relapses during the 12 months following therapy occurred in 9% (3 out of 32) of patients who responded to treatment with Osteofos.

Side Effects Of Osteofos Tablets (Generic Fosamax)

The most common side effects of are given below:
Gastrointestinal
abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid regurgitation, esophageal ulcer, vomiting, dysphagia, abdominal distention and gastritis
Musculoskeletal
musculoskeletal (bone, muscle or joint) pain, muscle cramp
Nervous System/Psychiatric
headache, dizziness
Special Senses
taste perversion
Rarely, rash and erythema have occurred.

Further Information

Additional Info: Prescribing Information

Tugain Foam | Generic Rogaine | Dosage | Uses | Side effects

Tugain Foam (Generic Rogaine) - Active Ingredient And Chemical structure

The active ingredient contained in Tugain Foam is Minoxidil. The structure is shown below

Generic Rogaine (Minoxidil) - Uses

Generic Rogaine (Minoxidil) in the form of Tugain Foam 5% is used to treat androgenic alopecia only in men.

Generic Forms and Brand names of Rogaine (Minoxidil)

Tugain Foam manufactured by Cipla Ltd., India is an effective treatment to stimulate hair growth and to slow balding. Rogaine which has the active ingredient Minoxidil is also sold as Regaine, Vanarex, Mintop and Loniten (oral), and Avacor Physician's Formulation and under various other brand names.

Tugain Foam (Minoxidil) - Preparations

Tugain Foam (Generic Rogaine) is available as cans of 60 grams.

Tugain Foam (Minoxidil) - Storage Requirements

Tugain Foam (Minoxidil) is to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Tugain Foam (Generic Rogaine) - Dosage

Tugain Foam is for external use only and should be used only as directed. Tugain Foam should be prevented from getting into your eyes, nose, or mouth. Do not swallow the medication. Apply Tugain Foam only when the hair and scalp are clean and dry.
Apply half a capful of Tugain Foam twice daily at 12-hour intervals to the scalp, beginning at the centre of the affected area and spreading the foam out to cover the entire affected area.
Each can of Generic Rogaine should last one month, if used as directed.
In order to obtain the best results, Tugain Foam should be allowed to remain on the scalp for about 4 hours before washing. The night-time application should be done 2-4 hours before going to bed to allow the medication to dry out.
Tugain Foam should be massaged gently into the scalp. A hair dryer should not be used to speed up the drying of the foam as it may decrease the effectiveness. Tugain Foam should not be mixed with any hair oil. The medicine should not be used more frequently than two times a day, or be taken orally or applied to any other part of the body to avoid the risk of adverse effects and unwanted hair growth. Using Tugain Foam more frequently or longer application time have no effect on hair growth. In case you miss any daily applications of Tugain Foam, the patient should continue with the next dose. Do not double your dose.
Wash your hands immediately after the application of Tugain Foam. Clinical experience with minoxidil (Generic Rogaine) shows that twice-daily applications for 4 months or more may be required before there is evidence of hair growth. To arrest hair fall, the medication should be used for 45 days or more. In case you stop taking the medication, most new hair that is gained will be lost within a few months after Generic Rogaine is stopped.

Tugain Foam (Generic Rogaine) - Contraindications

Tugain Foam (Generic Rogaine) is contraindicated in the following circumstances:

• Patients with a history of hypersensitivity any of the ingredients present in the medication.


• Patients with cardiac abnormalities.


• Children below 18 years of age, pregnant women and nursing mothers.


• Patients in whom the reason for hair loss is unknown.


• Patients using occlusive dressings or other medicines on the scalp.


• On a shaved scalp


• In patients whic have sudden and/or patchy hair loss.


• Patients with red, inflamed infection, or irritated or painful scalp (including psoriasis and sunburn).


• Patients with hypovolemic states (e.g., co-treatment with diuretics, dehydration, etc.)

Side Effects Of Tugain Foam (Generic Rogaine)

The most common side effects of minoxidil (Generic Rogaine) include burning or irritation of the eye, itching, redness or irritation at the treated area, as well as unwanted hair growth elsewhere on the body. Patients should stop treatment with Tugain Foam and seek medical attention immediately if they experience any of the following serious side effects: Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; dizziness; fainting; fast heartbeat; sudden, unexplained weight gain; swollen hands or feet.

Indocap Capsules | Generic Indocin | Dosage | Uses | Side effects

Indocap Capsules (Generic Indocin) - Active Ingredient And Chemical structure

The active ingredient contained in Indocap Capsules is Indomethacin. Indomethacin is practically insoluble in water and sparingly soluble in alcohol. The structure is shown below

Generic Indocin - Uses

Generic Indocin in the form of Indocap Capsules is used to treat the following:
1.Moderate to severe rheumatoid arthritis including acute flares of chronic disease.
2. Moderate to severe ankylosing spondylitis.
3. Moderate to severe osteoarthritis.
4. Acute painful shoulder (bursitis and/or tendinitis).

Generic Forms and Brand names of Indocin

Indocap Capsules manufactured by Jagsonpal Pharmaceuticals Limited, India is an effective treatment for moderate to severe rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Indocin which has the active ingredient Indomethacin is also sold as Indocid, Indochro and under various other brand names.

Indocap Capsules - Preparations

Indocap is available as Capsules of 25 mg and 75 mg .

Indocap Capsules - Storage Requirements

Indocap Capsules are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Indocap Capsules - Contraindications

Indocap Capsules (Indomethacin) capsules are contraindicated in patients with known hypersensitivity to indomethacin or any inactive ingredient present in Indocap capsules.
Indomethacin extended-release capsules should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Indocap Capsules (Indomethacin) are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Indocap Capsules - Dosage

The initial dosage of Indomethacin capsules (Indocap Capsules) is 25 mg twice a day or thrice a day. If this is well tolerated, the daily dosage may be increased by 25 or by 50 mg, if required, at weekly intervals until a satisfactory response is obtained or until a total daily dose of 150 to 200 mg is reached. Please consult your doctor for exact dosing instructions. The dosage is individualized.

Side Effects Of Indocap Capsules (Generic Indocin)

The most common side effects of are stomach pain, constipation, diarrhea gas, heartburn, nausea, vomiting, dizziness . Serious side effects that may occur are heart attack, stroke, high blood pressure, heart failure from body swelling (fluid retention), kidney problems including kidney failure,bleeding and ulcers in the stomach and intestine low red blood cells (anemia), life-threatening skin reactions, life-threatening allergic reactions, liver problems including liver failure and asthma attacks in people who have asthma.

Further Information

Additional Info: Prescribing Information

Naprosyn Tablets | Generic Aleve | Dosage | Uses | Side effects

Naprosyn Tablets (Generic Aleve) - Active Ingredient And Chemical structure

The active ingredient contained in Naprosyn Tablets is Naproxen Sodium. Naproxen is an odorless, white to off-white crystalline substance. It is lipid soluble, practically insoluble in water at low pH and freely soluble in water at high pH.. The structure is shown below

Generic Forms and Brand names of Aleve (Naproxen Sodium)

Naprosyn Tablets are manufactured by RPG Lifesciences Ltd., India under license of F. Hoffmann- La Roche Ltd. Switzerland. Aleve which has the active ingredient is also sold as Anaprox Naprelan. Antalgin, Feminax Ultra, Flanax, Inza, Midol Extended Relief, Miranax, Nalgesin,Naposin, Naprogesic, Naprosyn, Narocin, Proxen, Synflex, Xenobid and under various other brand names.

Generic Aleve (Naprosyn Tablets) - Uses

Generic Aleve in the form of Naprosyn Tablets is used to treat signs and symptoms of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis.

Naprosyn Tablets (Generic Aleve) - Preparations

Naprosyn is available as tablets of 250 mg, 375 mg and 500 mg for oral administration.

Naprosyn Tablets (Generic Aleve) - Storage Requirements

Naprosyn Tablets are to be stored at room temperature (15°C to 30°C). Store away from heat, moisture, and light.

Naprosyn Tablets - Dosage

The lowest effective dose for the shortest possible duration should be used. After observing the response to initial therapy with Naprosyn Tablets, the dose and frequency should be adjusted to suit an individual patient’s needs. For the treatment of Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis the adult dose is 250 mg or 375 mg or 500 mg twice daily.

Side Effects Of Naprosyn Tablets (Generic Aleve)

The most common side effects of are stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting and dizziness.
Serious side effects include heart attack, stroke, high blood pressure, heart failure from body swelling (fluid retention), kidney problems including kidney failure, bleeding and ulcers in the stomach and intestine, low red blood cells (anemia), life-threatening skin reactions, life-threatening allergic reactions, liver problems including liver failure, asthma attacks in people who have asthma

Further Information

Additional Info: Prescribing Information

Depo-Provera Contraceptive Injection | Dosage | Uses | Side effects

Depo-Provera Contraceptive Injection - Active Ingredient And Chemical structure

The active ingredient contained in Depo-Provera is medroxyprogesterone acetate, which is a a derivative of progesterone. Medroxyprogesterone acetate is a white to off-white odorless crystalline powder. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water. The structure is shown below

Depo-Provera (Medroxyprogesterone Acetate) - Uses

Depo-Provera in the form of Depo-Provera Contraceptive Injection is used for the prevention of pregnancy. Depo-Provera is also used as adjunctive therapy and palliative treatment of inoperable, recurrent, and metastatic endometrial or renal carcinoma.

Generic Forms and Brand names of Depo-Provera (Medroxyprogesterone Acetate)

Depo-Provera Contraceptive Injection manufactured by Pfizer, Belgium is an effective treatment for the prevention of pregnancy.

Depo-Provera Contraceptive Injection - Preparations

Depo-Provera for intramuscular (IM) injection is available in vials and prefilled syringes. Each vial contains 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.

Depo-Provera Contraceptive Injection - Contraindication

Depo-Provera is contraindicated in known or suspected cases pregnancy or if the patient has known hypersensitivity to medroxyprogesterone acetate or any other inactive ingredients present in Depo-Provera. It is also contraindicated in patients that have active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease. Other cases where Depo-Provera is contrindicated include Known or suspected malignancy of breast, Significant liver disease and Undiagnosed vaginal bleeding.

Depo-Provera Contraceptive Injection - Storage Requirements

Depo-Provera Contraceptive Injection is be stored upright at controlled room temperature at (20°C to 25°C). Store away from heat, moisture, and light.

Warnings and Precautions When Using Depo-Provera Contraceptive Injection

Below are mentioned the warnings and precautions when Using Depo-Provera Contraceptive Injection:
Depo-Provera Contraceptive Injection (CI) use reduces serum estrogen levels and is associated with significant loss of bone mineral density (BMD).
Depo-Provera CI should be discontinued in patients who develop thrombosis
Women with breast nodules or a strong family history of breast cancer should be monitored carefully.
Consider ectopic pregnancy if a woman using Depo-Provera CI becomes pregnant or complains of severe abdominal pain.
Provide emergency medical treatment in case a patient develops Anaphylaxis and Anaphylactoid Reaction.
Depo-Provera CI should be discontinued if jaundice or disturbances of liver function develop.
There have been a few reported cases of convulsions in patients who were treated with Depo-Provera CI.
Diabetic patients should be monitored carefully for Carbohydrate Metabolism as a decrease in glucose tolerance has been observed in some patients .

Depo-Provera Contraceptive Injection - Dosage

The recommended dose is 150 mg of Depo-Provera Contraceptive Injection every 3 months (13 weeks) administered by deep Intramuscular injection in the gluteal or deltoid muscle.

Side Effects Of Depo-Provera Contraceptive Injection (Medroxyprogesterone Acetate)

The most common side effects of Depo-Provera Contraceptive Injection are menstrual irregularities (bleeding or spotting), abdominal pain/discomfort, weight gain, dizziness, headache, nervousness and decreased libido.

Further Information

Prescribing Information